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Abstract
The mycobacterial cell envelope has been implicated in the pathogenicity of tuberculosis and therefore has been a prime
target for the identification and characterization of surface proteins with potential application in drug and vaccine
development. In this study, the genome of Mycobacterium tuberculosis H37Rv was screened using Machine Learning tools
that included feature-based predictors, general localizers and transmembrane topology predictors to identify proteins that
are potentially secreted to the surface of M. tuberculosis, or to the extracellular milieu through different secretory pathways.
The subcellular localization of a set of 8 hypothetically secreted/surface candidate proteins was experimentally assessed by
cellular fractionation and immunoelectron microscopy (IEM) to determine the reliability of the computational methodology
proposed here, using 4 secreted/surface proteins with experimental confirmation as positive controls and 2 cytoplasmic
proteins as negative controls. Subcellular fractionation and IEM studies provided evidence that the candidate proteins
Rv0403c, Rv3630, Rv1022, Rv0835, Rv0361 and Rv0178 are secreted either to the mycobacterial surface or to the
extracellular milieu. Surface localization was also confirmed for the positive controls, whereas negative controls were
located on the cytoplasm. Based on statistical learning methods, we obtained computational subcellular localization
predictions that were experimentally assessed and allowed us to construct a computational protocol with experimental
support that allowed us to identify a new set of secreted/surface proteins as potential vaccine candidates.
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Introduction
According to the Statistics reported by the World Health
Organization, Mycobacterium tuberculosis causes 9.27 million new
cases of tuberculosis (TB) each year and approximately 1.7 million
deaths among infected people worldwide [1]. Host–pathogen
interactions leading to mycobacterial infection are mediated by a
variety of cell receptor ligands, signal transduction proteins and
enzymes, among others [2,3]. A large number of these molecules
are exposed on the surface of the tuberculous bacillus where they
are in direct contact with the host’s cells and likely to play key roles
in the initial stages of the bacillus invasion, virulence, pathogenesis
and survival inside host cells [4]. This has led to focusing most
vaccine and drug development efforts on the identification of
mycobacterial cell surface and secreted proteins, a goal that has
been enormously facilitated by the publication of the complete
genomic sequence of M. tuberculosis (H37Rv strain). However,
despite the large amount of data available, the structure, function
and localization of a large number of hypothetical or putative
proteins have not been yet defined [5,6], mainly due to
methodological difficulties related to proteomic and transcriptomic
analyses [7].
Secretion of mycobacterial proteins to the membrane and the
extracellular milieu is tightly regulated through different secretory
routes or pathways [8,9]. In bacteria one of the best characterized
secretory systems is the Sec-dependent pathway (or classical
pathway), which transports unfolded protein precursors to the cell
membrane [10–12]. There are other protein secretion mecha-
nisms alternative to the classical secretory pathway such as the
twin-arginine translocation (Tat) and lipoprotein secretion path-
ways. Tat has been extensively studied in Escherichia coli (Gram-
negative bacteria) and Bacillus subtilis (Gram-positive bacteria)
where it is known to mediate secretion of folded proteins
containing a conserved consensus N-terminal sequence. In
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pathway contain a consensus sequence known as the ‘‘lipobox’’
motif at the signal sequence’s C-terminal portion [13–15], which
drives prolipoprotein maturation and lipoprotein anchoring to the
cell surface [16]. Other proteins are secreted through different
mechanisms despite not containing a distinguishable secretion
signal sequence and are commonly referred to as non-classically
secreted proteins [17–19].
A fundamental goal of cell biology is to define the functions of
proteins in the context of the compartments inside which they are
organized within the cellular environment [20]. To facilitate
making inferences regarding protein function, annotating genomes
and designing proteomics experiments [21,22], proteins reported
in the Swiss-Prot protein database [23] have been categorized
according to their localization into cytoplasmic, membrane-
anchored, cell wall, and extracellular proteins (lipid anchored,
secreted and bacteriocine-like proteins) [24].
The identification of both the secretory mechanisms and the
subcellular localization of proteins are supported by two
computational strategies commonly referred to as featured-based
and general localization approaches, respectively; a distinction
made based on the different computational protocols available for
protein selection [25]. The first approach is based on sequence
pattern or motif recognition, while the second one consists in
extracting general amino acid profiles. These two approaches can
be combined to postulate better subcellular localization/secretion
predictions with the aim of identifying secreted/surface proteins.
Bearing in mind this idea and that only a reduced number of
mycobacterial surface proteins are currently annotated, this study
was divided into two phases: (a) a computational and (b) an
experimental phase which was meant to validate the first phase.
In the computational phase, the genome of M. tuberculosis
H37Rv [5] was screened with Machine Learning tools (feature-
based tools, general localizers and transmembrane topology
predictors) to identify proteins that are likely secreted to the
mycobacterial surface or the extracellular milieu. The first
approach involved the use of the featured-based tools SignalP
3.0 [26], TatP 1.0 [27], LipoP 1.0 [28] and SecretomeP 2.0 [29],
while the general localization predictors PA-SUB version 2.5
included in Proteome Analyst 3.0 [30], Gpos-PLoc [22] and
PSORTb version 2.0.4 [21] were used for the second approach.
The mycobacterial cell envelope has a complex architectural
rearrangement with three well differentiated structures of unique
composition. The inner layer of plasma membrane is composed
mainly of cardiolipin, phosphatidylglycerol, phosphatidylethanol-
amine, and phosphatidyl mannosides, which are precursors of
lipoarabinomanan (LAM). The middle layer is the cell wall that is
mainly composed of free lipids, proteins and peptidoglycan, which
is covalently bonded to one molecule of arabinogalactan and
esterified with mycolic acids. Finally, the capsule or outer layer is
composed of polysaccharides such as mannose and arabinoman-
nan, proteins and lipids [31].
Some of the most distinctive morphological characteristics of
mycobacteria are precisely due to the composition and structure of
the mycobacterial cell envelope, including resistance to decolor-
ation by acid alcohol in Gram staining, its characteristic ‘‘strings
and tangles’’ appearance of growth, resistance to drying and to
treatments with alkali and physical and chemical agents [32].
Particularly, the resistance of mycobacteria to the most commonly
used antimicrobial agents is attributable to the low permeability of
the mycobacterial cell envelope, a characteristic that is conferred
essentially by the cell wall layer of mycolic acids [33]. Given its
complexity, the Machine Learning tools used in this study were
first validated regarding their predictive capacity to classify
mycobacterial proteins [34], and the transmembrane topology of
the potentially secreted/surface proteins was determined using
TMHMM 2.0 [35] and Phobius [36]. The aim of this study was to
determine, based on experimental methodologies, that secreted/
surface mycobacterial proteins could be identified using compu-
tational approaches.
For such purpose, a set of hypothetically secreted/surface
mycobacterial candidate proteins were chosen based on the
following criteria: (a) prediction of secretion by only one of the four
feature-based tools with a probability score of $0.5 [25–29], (b)
prediction of cytoplasmic or extracellular localization by at least 2
of the 3 general localizers, (c) prediction of more than one
transmembrane helix, preferably not located in the N-terminal
region, (d) preferably having no experimental confirmation of
secretion/surface localization (a special case occurred with
proteins predicted proteins by SecretomeP 2.0 and LipoP 1.0),
and (e) not being included within the training sets of any of the
Machine-Learning Tools used in this study.
Four proteins were selected from the set of secreted/surface
proteins experimentally identified by Gu et al. [37] and Sinha et al.
[38] as positive controls, while two proteins were selected from the
set of cytoplasmic proteins reported in the TB Structural
Genomics Consortium (TBsgc) protein database as negative
controls [6]. Once these the final protein sets had been defined
as shown in Table 1, linear B cell epitopes were predicted using
classical methods that assign values to each amino acid according
to their physicochemical properties and therefore allowed selecting
peptides based on inferences made regarding their probable
antigenic activity [39,40]. Such peptides were synthesized as
polymers and were inoculated into rabbits to obtain specific
antisera that were used in the experimental phase to assess protein
localization by immunoblotting analysis of mycobacterial subcel-
lular fractions and IEM studies so as to evaluate the accuracy of
the computational predictions.
Results
Computational phase
The computational screening of the 3,924 open reading frames
(ORFs) reported in the M. tuberculosis H37Rv genome with the
feature-based tools reported a total of 825 proteins that are likely
Author Summary
Since the publication of the Mycobacterium tuberculosis
genome in 1998, great expectations have emerged
regarding speeding up the process of developing vaccines
against tuberculosis. Our group has been focused on
identifying molecules localized on the mycobacterial
surface that could act as ligands facilitating this pathogen’s
entry into host cells. Immune responses exerted against
these proteins might block receptor-ligand interactions,
thus hampering mycobacterial invasion. Since protein
fragments involved in these interactions might serve as
vaccine candidates and, taking into account that a
relatively small number of mycobacterial surface proteins
have been experimentally identified to date due to the
inherent difficulty of proteomics studies for characterizing
surface proteins, in this study, we used Machine Learning-
based tools available on the World Wide Web to obtain
accurate predictions of surface and secreted proteins from
this pathogen and found experimental support of such
predictions for a group of candidate proteins selected
based on novel criteria.
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These 825 proteins were independently predicted by a single
feature-based tool (each representing a different secretory
mechanism) with a probability score of $0.5 as follows: 162
proteins were exclusively predicted by SignalP 3.0, 106 only by
TatP 1.0, 1 only by LipoP 1.0 and 556 only by SecretomeP 2.0.
These proteins were then screened with the general localizers and
transmembrane topology predictors and 2 candidate proteins were
chosen per secretory mechanism with the aim of assessing their
localization in the experimental phase. Candidate proteins were
selected based on the following criteria: they had to contain at least
one predicted transmembrane helix located preferably outside the
N-terminal region. Secretion of the candidate proteins to the
cytoplasmic membrane or the extracellular milieu had to be
predicted by at least two of the general localizers. Preferably,
candidate proteins should not have been located in the surface of
M. tuberculosis by experimental methodologies yet and should not
be part of the training datasets of the Machine-Learning Tools
used in this study.
According to such criteria, the following candidate proteins
were chosen from the sets of proteins predicted by each of the
feature-based tools: Rv0403c and Rv1733c from the set of proteins
predicted by SignalP 3.0, Rv3069 and Rv3630 from the set
predicted by TatP 1.0, Rv1022 and Rv0835 (the latter also
predicted by SignalP 3.0 in our computational analysis and
identified by Malen et al. [41] as an exported protein using
proteomics) from the set of proteins predicted by LipoP 1.0, and
finally Rv0361 and Rv0178 from the set of proteins predicted by
SecretomeP 2.0 (Table 2).
It should be taken into account that in case of the proteins
predicted by SecretomeP 2.0, Rv0361 was identified by Xiong
et al. as an integral membrane protein using one-dimensional (1D)
gel electrophoresis and liquid chromatography electrospray
ionization tandem mass spectrometry (MS) [42], and Rv0178
was identified by Gu et al. in membrane fraction by 1D sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
coupled with microcapillary liquid chromatography LC-MS/MS
[37]. These two proteins were chosen as candidates to be assessed
in the experimental phase despite having experimental confirma-
tion of surface localization, because they could be used to evaluate
the accuracy of SecretomeP 2.0 predictions regarding the non-
classical secretion problem. As a result, three of the secreted/
surface candidate proteins had been experimentally confirmed by
other authors (without the use of bioinformatics tools) while the
localization of the other 3 proteins had not been experimentally
determined previously.
The same screening over the 100 proteins reported Gu et al. [37]
and Sinha et al. [38] identified 84 as possible secreted/surface
proteins. Six of these proteins were only predicted by SignalP 3.0,
1 protein only by TatP 1.0, none by LipoP 1.0, and 48 only by
SecretomeP 2.0. On the basis of the screening done with the
general localizers and the topology predictors, Rv0200, Rv1280c
and Rv0556 were chosen to be assessed in the experimental phase
as positive controls of SignalP 3.0, TatP 1.0 and SecretomeP 2.0
predictions, respectively (Table 2). Since no proteins were
exclusively predicted by LipoP 1.0, Rv0418 (predicted also by
Signal 3.0 and SecretomeP 2.0) was selected as the positive control
for LipoP 1.0. On the other hand, Rv0126 [43–45] and Rv1326c
[46,47] were selected as negative controls based on previously
described reports. The same computational screening was applied
to positive and negative controls to compare predictions on these
proteins with predictions on the candidate proteins (Table 2).
The results of the computational screening with the feature-
based tools, the general localizers and the transmembrane
topology predictors on the complete genome of M. tuberculosis
H37Rv, from which the candidate proteins were selected, are
shown discriminated by feature-based tool in Tables S1, S2, S3
and S4, while the results for the 100 proteins experimentally
identified by Gu et al. [37] and Sinha et al. [38] from which positive
controls were selected are shown in Table S5 and the screening on
the cytoplasmic proteins reported in TBsgc from which negative
controls were selected are shown in Table S6.
The transition from the computational phase to the experi-
mental phase consisted on predicting linear B cell epitopes on the
candidate, positive and negative proteins using ANalyse THE
PROTeins (AntheProt) [48] and BepiPred 1.0 [39]. These
epitopes were synthesized and inoculated into rabbits to obtain
antisera specific against each protein. Rabbit hyperimmune sera
were used in immunoblotting assays to assess the presence of each
protein in M. tuberculosis sonicate and its localization by IEM.
Peptide sequences and each protein’s molecular weight are shown
in Table 3. It is important to mention that proteins that are labeled
with an asterisk in this table correspond to proteins for which sera
were already available in the FIDIC’s sera collection and therefore
were not subjected to the prediction of linear B cell epitopes.
Experimental phase
The localization of the candidate, positive and negative control
proteins was assessed using sera raised against linear B cell epitope
polymers of each protein.
Regarding proteins that were predicted to be secreted via the
classical secretion pathway by SignalP 3.0, sera raised against the
positive control Rv0200 detected a band of ,26.2 kDa in total
protein sonicate (TPS) and in the membrane fraction (Figure 1A),
which is consistent with the expected molecular weight of this
protein (24.0 kDa). Rv0403c, one of the candidate proteins for this
pathway was also detected in TPS and the membrane fraction by
its specific hyperimmune sera at ,15.74 kDa, which is close to this
Table 1. Number of proteins in each of the protein sets explored in this study.
Localization Source Nn
Candidate proteins hypothetically secreted/surface M. tuberculosis H37Rv genome 3,924 8
Positive control proteins secreted/surface Gu et al. and Sinha et al. 100 4
Negative control proteins cytoplasmic TBsgc 9 2
N: total number of proteins in the raw data sets explored in the computational phase of the study. Feature-based, general localization and transmembrane topology
predictions obtained for each protein are shown in Tables S1, S2, S3 and S4 (M. tuberculosis H37Rv genome ORFs), Tables S5 (proteins reported by Gu et al. and Sinha
et al.) and S6 (cytoplasmic proteins reported in TBsgc: TB Structural Genomics Consortium).
n: number of proteins from each protein set source selected based the criteria established in this study whose subcellular localization was assessed in the experimental
phase.
doi:10.1371/journal.pcbi.1000824.t001
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proteins were recognized by rabbit antisera raised against
Rv1733c, the second candidate protein for this pathway (expected
molecular weight of 22.5 kDa).
With respect to proteins predicted to be secreted via the twin-
arginine translocation pathway according to TatP 1.0, the positive
control protein Rv1280c was detected in TPS as a band of
,65.6 kDa close to the expected molecular weight of 63.5 kDa
but was not detected in any of the subcellular fractions or in
culture filtrate (Figure 3A). Similarly, the candidate protein
Rv3630 was detected in TPS at ,45.2 kDa (theoretical molecular
weight: 43.5 kDa), but was not observed in any of the subcellular
fractions nor in culture filtrate (Figure 4A). Antisera raised against
Rv3069, the other candidate protein for this pathway, did not
recognize this protein in TPS nor in any of the subcellular
fractions (expected molecular weight of 14.3 kDa).
Of the group of lipoproteins predicted by LipoP 1.0, the positive
control Rv0418 was only detected in TPS at ,51.9 kDa, which is
close to the theoretical weight of 52.0 kDa expected for this
protein (Figure 5A). Sera raised against the candidate lipoprotein
Rv1022 did not detect this protein in TPS at the expected
molecular weight of 25.8 kDa; however, it did recognize a band of
,25.12 kDa in membrane fraction and culture filtrate
(Figure 6A).Sera raised against the other candidate lipoprotein
Rv0835 recognized a band of ,22.8 kDa (expected molecular
weight: 22.9 kDa) in TPS and culture filtrate (Figure 7A).
The results obtained for the group of non-classically secreted
proteins predicted by SecretomeP 2.0 showed detection of the
positive control Rv0556 in TPS at ,18.0 kDa (theoretical
molecular weight: 18.8 kDa) but not in culture filtrate nor in
any of the subcellular fractions (Figure 8A).Sera raised against the
candidate protein Rv0361, which has an expected molecular
weight of 30.0 kDa, detected a band of ,29.0 kDa in TPS and in
the membrane fraction, but also detected other bands in culture
filtrate and the cytoplasmic fraction at molecular weights different
from the one expected for this protein (Figure 9A). Similarly,
Table 3. Sequences of the linear B cell epitopes synthesized for candidate proteins, positive and negative controls, molecular
weights expected and observed in the immunoblotting assays.
Computational phase Experimental phase
Peptide sequence Monomer length (aa)
a E (kDa) O (kDa)
*Rv0200 (+) LVLLVVEGVAINFWLLRRD 19 24.032 26.2
QAARALRVTLTKRGSGWLV 19
*Rv1733c AAAGTAVQDSRSHVY 15 22.461 ND
TATSAPPRTKITVPARWVVNY 21
*Rv0403c AAVTVSRLHSVFGSHQHAPD 20 15.262 15.74
VIREERIVNAYHAHTSTLVKSA 22
Rv1280c (+) ALRASFQGKSRPWTQTRYWA 20 63.484 65.6
DGYQDNSGVVAYNPEQAKRE 20
Rv3069 AALSALAIPDPARWPWPTFT 20 14.303 ND
MPNHDYRELAAVFAGGALGA 20
Rv3630 ADGRRTHPLRVSGMVGLGSL 20 43.491 45.2
LTRAPLLVPLTAMQGNLIAH 20
Rv0418 (+) LKMAGKTAQDTSFDGRSDYD 20 52.049 51.92
VAAPADDSPGCSPSDYDRLP 20
*Rv1022 ASSTTWQLSLFITDGVPPPP 20 25.835 ND
DGIANVDNIDDAALSAAGYL 20
*Rv0835 VDSLIVSIEDVRRIANYEEL 20 22.905 22.81
LDRPDASTVRIGAAGWSHVY 20
*Rv0556 (+) TRGRIVLRWLRIAVLIVTGL 20 18.759 17.96
TPDRITYRPQLGVLYPSELS 20
*Rv0361 DAETETVVITTSDNDAAVTQ 20 29.986 29.0
RSLDLQFRDDQWKITQSSSN 20
*Rv0178 STDTASAATEGHRGEIDAAG 20 25.915 24.4
AVESLSGRDAVAIVYTNTTT 20
Rv1326c (2) MSRSEKLTGEHLAPEPAEMA 20 81.739 ND
RFDGTPLYEHSDPKRGEQLD 20
Rv0126 (2) TSERYTDARIIFVDTEESNW 20 68.601 68.9
VTDEERDYMYAEYAKDPRMK 20
E: expected molecular weight based on sequence (in kDa). O: observed molecular weight (kDa) in immunoblotting assays.
*Proteins for which sera were already available and therefore did not undergo B cell prediction.
aMonomer lengths do not include the cysteine and glycine (CG) residues added at the peptide’s ends to enable polymerization.
ND: no data are available for proteins that were not recognized in M. tuberculosis H37Rv TPS by the immune sera.
doi:10.1371/journal.pcbi.1000824.t003
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detected in TPS and in the membrane fraction at ,24.4 kDa,
which is close to the molecular weight of 25.9 kDa estimated for
this protein. Other bands with molecular weights different from
the one expected for this protein were also detected in culture
filtrate (Figure 10A).
Finally, sera raised against the negative control protein Rv0126
(68.6 kDa) detected a band of ,68.9 kDa in TPS (Figure 11A),
whereas no proteins were recognized in assays by sera raised
against the negative control protein Rv1326c (81.7 kDa) (data not
shown).
In addition, the subcellular fractions were assessed with
Colloidal Coomassie Blue Staining of an SDS-gel and sera raised
against crude sonicate of M. tuberculosis H37Rv by Western blot.
The results of Colloidal Coomassie Blue gel staining showed
numerous proteins with different migration distances in the
different fractions and in the culture filtrate (Figure 12A). As
observed in Figure 12B, several protein bands of strong intensity
were recognized in all subcellular fractions and culture filtrate, as
well as in TPS by sera raised against a total sonicate of M.
tuberculosis, therefore indicating that antibody and cell fraction
concentrations were appropriate. None of the pre-immune sera
recognized proteins in TPS (pre-immune lanes in Figures 1–11),
thus indicating that antisera were specific against their corre-
sponding mycobacterial antigens.
The same sera raised against B cell epitopes of the three groups
of proteins (candidate, positive and negative control proteins) were
used in IEM experiments to determine the localization of the
candidate proteins and assess whether the localization of the
positive and negative controls agreed with their reported
localizations. It should be noted that IEM studies were not carried
out for Rv1733c, Rv3069 and Rv1326c due to the negative
reactivity shown by their antisera, which is probably indicating
that peptides used for immunization corresponded to conserved
immunologically silent sequences. The results showed colloidal
gold particles of about 10 nm in the surface of intact M. tuberculosis
H37Rv bacilli when assessing sera raised against Rv0200
(Figure 1B), Rv0403c (Figure 2B), Rv1280c (Figure 3B), Rv3630
Figure 1. Experimental assessment of the subcellular localization of Rv0200, which was selected as positive control protein for
surface/secreted predictions of SignalP 3.0. (A) Immunoblotting assessment of the presence of Rv0200 in TPS: total protein sonicate, W: cell
wall, M: membrane, C: cytosol and F: culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-
immune serum showing no recognition of any mycobacterial protein. Molecular weight marker is shown on the left (P7709S ColorPlus Prestained
Protein Marker, New England Biolabs) and the molecular weight observed for Rv0200 is shown to the right. (B) IEM assessment of the presence of
Rv0200 on the surface of intact M. tuberculosis H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm
colloidal gold particles are indicated by the black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results
showed detection of Rv0200 in TPS, membrane and surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g001
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(Figure 7B), Rv0556 (Figure 8B), Rv0361 (Figure 9B), and Rv0178
(Figure 10B), whereas colloidal gold particles were observed only
in the cytoplasm with sera raised against the cytoplasmic protein
Rv0126 (Figure 11B). Pre-immune sera showed no recognition of
any mycobacterial protein (panel C in Figures 1–11), and sera
raised against total M. tuberculosis H37Rv protein sonicate
recognized proteins in all subcellular compartments (Figure 12C).
These IEM results are consistent with the subcellular localizations
predicted for these proteins in the computational phase (Table 2).
Discussion
The use of bioinformatics tools and web-available databases has
facilitated the identification of proteins that are expressed on the
cell surface or secreted to the extracellular milieu of pathogenic
organisms by searching for intrinsic secretion signals and
membrane anchoring features on the sequences of hypothetical
proteins encoded in their genomes. Although the different
computational methods currently available can be used to predict
the subcellular localization of a given protein, their use has to be
first validated by experimentally determining the accuracy of their
predictions.
The large number of proteins predicted independently by
SecretomeP 2.0 in this study could be explained by the capacity of
this tool to identify all proteins that are secreted but do not contain
a signal sequence (probability of signal sequence absence), which
would include proteins that are secreted through unknown
secretion mechanisms. Even though SecretomeP 2.0 is considered
a feature-based tool, its predictions are not based on the
identification of specific sequence feature or motif, as occurs with
Signal 3.0, TatP 1.0 and LipoP 1.0, and therefore this tool can
identify proteins independently of their secretory mechanism [29].
The experimental phase provided evidence of secretion to the
mycobacterial surface for six candidate proteins. In the case of
proteins predicted to be secreted via the Sec-dependent pathway,
the candidate protein Rv0403c contains two transmembrane
helices according to TMHMM 2.0, the first of which is located
between amino acids 7 and 29 and overlaps with the signal
sequence predicted by both SignalP 3.0 and Phobius between
amino acids 1 and 33 (Table 2). Rv0403c was detected in TPS as
well as in the membrane fraction and was observed in the surface
of intact bacilli by IEM (Figure 2A and B). All these results are is
consistent with the predictions of the Machine Learning tools and
would indicate that this protein is anchored to mycobacterial
surface and involved in cell wall and cell processes, as appears
annotated in TubercuList.
Rv3630, which was predicted in the computational phase to be
secreted via the Tat secretory machinery, is also annotated in
TubercuList as a probable conserved integral membrane protein
Figure 2. Experimental assessment of the subcellular localization of the candidate protein Rv0403c predicted as a surface/secreted
by SignalP 3.0. (A) Immunoblotting assessment of the presence of Rv0403c in TPS: total protein sonicate, W: cell wall, M: membrane, C: cytosol and
F: culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-immune serum showing no recognition of
any mycobacterial protein. Molecular weight marker is shown on the left (P7709S ColorPlus Prestained Protein Marker, New England Biolabs) and the
molecular weight observed for Rv0403c is shown to the right. (B) IEM assessment of the presence of Rv0403c on the surface of intact M. tuberculosis
H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm colloidal gold particles are indicated by the
black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results showed detection of Rv0403c in TPS,
membrane and surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g002
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contain a signal sequence between amino acids 1 and 40
(according to TatP 1.0), and to have 11 transmembrane helices
(according to TMHMM 2.0), whereas Phobius predicted 12
transmembrane helices and no signal sequence (Table 2). These
predictions of transmembrane helices are in agreement with this
protein’s annotation as well as with the predictions of localization
n the plasma membrane by the general localization tools. This
protein was detected in TPS and the surface of intact bacilli by
rabbit sera but was not recognized in any of the subcellular
fractions nor in culture filtrate (Figure 4A and B), probably due to
its low abundance in these fractions, as suggested by its weak
reactivity in immunoblotting analyses and the few gold particles
observed in IEM studies, or perhaps due to the low immunoge-
nicity of the chemically synthesized peptides used to detect its
presence.
In Rv1022, which was predicted by LipoP 1.0, there is no
evidence of transmembrane helices since Phobius shows a signal
sequence in the same region predicted to be a transmembrane
helix by TMHMM 2.0 (Table 2). General subcellular localizers
indicate that this protein is intracytoplasmic, which is not
consistent with the known subcellular localization of lipoproteins
because even though lipoproteins do not contain transmembrane
helices, it seems that the lipobox motif and the Lgt and Lsp
cleavage sites are necessary and sufficient to ensure their
anchorage to the membrane [16,49]. These computational
predictions, together with the detection of Rv1022 in culture
filtrate (Figure 6A) and on the surface of intact bacilli (Figure 6B)
indicate that secretion of this protein is driven by the signal
sequence (nevertheless, gold particles might also correspond to any
of the other proteins that were detected in immunoblotting assays),
while the lack of transmembrane helices might indicate that it is
secreted to the extracellular milieu and is consistent with the lack
of any of the residues in position +2 known to be relevant for
membrane anchorage [50,51]. The presence of this protein both
in membrane and culture filtrate could be explained by the
gradual liberation of proteins during mycobacterial growth in
culture, but it is intriguing that the protein was not also detected in
the cell wall fraction considering that mycobacterial secreted
proteins are usually expressed in large amounts during the first
Figure 3. Experimental assessment of the subcellular localization of protein Rv1280c, which was selected as positive control
protein for surface/secreted predictions of TatP 1.0. (A) Immunoblotting assessment of the presence of Rv1280c in TPS: total protein sonicate,
W: cell wall, M: membrane, C: cytosol and F: culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-
immune serum showing no recognition of any mycobacterial protein. Molecular weight marker is shown on the left (P7708S ColorPlus Prestained
Protein Marker, New England Biolabs) and the molecular weight observed for Rv1280c is shown to the right. (B) IEM assessment of the presence of
Rv1280c on the surface of intact M. tuberculosis H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-
nm colloidal gold particles are indicated by the black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results
showed detection of Rv1280c in TPS and surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g003
Secreted/Surface Mycobacterial Proteins
PLoS Computational Biology | www.ploscompbiol.org 8 June 2010 | Volume 6 | Issue 6 | e1000824days of culture and can be found in trace amounts inside the
bacillus [52]. Regarding Rv0835, the predictions indicated that it
contains a signal sequence (which was also predicted by Phobius),
is not anchored to membrane and has no transmembrane regions.
Interestingly, Gpos-PLoc and PSORTb v.2.0.4 located this
protein in the cytoplasm, whereas PA-SUB v.2.5 located it in
the plasma membrane (Table 2). In the experimental phase, this
protein was detected in TPS and culture filtrate (Figure 7A), which
provides additional evidence that this hypothetical lipoprotein is
exported to the extracellular milieu, as reported by Malen et al.
[41]. This protein is similar to the positive control protein Rv0418
in that it has been reported as a secreted/surface protein by
proteomics studies and both are hypothetical lipoproteins;
however, the positive control was identified both in the membrane
and the culture filtrate by Gu et al. [37] and Mawuenyega et al.
[53], in contrast to the candidate protein Rv0835 which has been
only reported in the culture filtrate [41].
Regarding non-classical secretion, important mycobacterial
proteins such as ESAT-6 (Rv3875) and CFP-10 (Rv3874) have
been detected in culture filtrate even though they do not seem to
contain a signal sequence in their N-terminal regions [54]. Both of
these proteins were positively identified by SecretomeP 2.0 in the
computational phase (Table S4), therefore giving additional
support to the use of this tool in our study.
The other two protein candidates, Rv0361 and Rv0178, chosen
from the set of secreted/surface proteins predicted by SecretomeP
2.0, have no predicted signal peptides according to the other
feature-based tools (Table 2), which indicates that they are not
Figure 4. Experimental assessment of the subcellular localization of the candidate protein Rv3630 predicted as a surface/secreted
by TatP 1.0. (A) Immunoblotting assessment of the presence of Rv3630 in TPS: total protein sonicate, W: cell wall, M: membrane, C: cytosol and F:
culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-immune serum showing no recognition of
any mycobacterial protein. Molecular weight marker is shown on the left (P7708S ColorPlus Prestained Protein Marker, New England Biolabs) and the
molecular weight observed for Rv3630 is shown to the right. (B) IEM assessment of the presence of Rv3630 on the surface of intact M. tuberculosis
H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm colloidal gold particles are indicated by the
black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results showed detection of Rv3630 in TPS and
surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g004
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rather through yet unknown mechanisms. Both proteins were
identified in TPS, in the membrane fraction as well as in the
bacillus surface (Figures 9 and 10); however, sera raised against
Rv0178 also recognized protein bands of lower molecular weight
in immunoblotting assays, thus suggesting a potential cleavage of
this protein.
According to the computational analysis, Rv0178 has a
transmembrane helix, as predicted by Phobius, and is located in
the extracellular compartment, according to Gpos-PLoc. Previous
studies suggest that the mycobacterial mce1 operon, which contains
the gene encoding Rv0178, plays an important role in mycobac-
terial invasion and persistent infection in mice, as well as a possible
role in mycobacterial virulence [55,56].
The detection of intense bands at the same molecular weight in
immunoblotting analyses of TPS suggests that subcellular fractions
were not completely pure (Figure 12B), which could explain why
subcellular fractionation results for positive and negative control
proteins (e.g. Rv0126) were not in some cases consistent with their
known localizations; nevertheless, rabbit sera did recognize these
proteins in their expected localization in IEM studies (surface or
cytoplasm). For this reason, IEM results were considered more
reliable than the ones obtained in immunoblotting assays with
subcellular fractions when analyzing the localization of each
candidate protein.
On the other hand, the absence of recognition of Rv1326c,
Rv1733c and Rv3069 by rabbit antisera suggests that epitopes
were probably not strong enough as to induce a good antibody
response and therefore obtain large amounts of antibodies for
immunoblotting and IEM assays, or alternatively, that the peptide
sequences chosen in this study were immunologically silent, as
occurs with malarial high activity binding peptides.
Predicting protein regions that are likely to be exposed on the
protein surface and therefore accessible to interaction with host
immune system molecules (humoral or cellular) is of key
importance both in the design of vaccine components and the
development of immunodiagnostic methods. Linear B cell epitopes
predicted and synthesized in this study corresponded to contin-
uous epitopes that were selected by using classical sequence
prediction methodologies (based on the physicochemical profile of
Figure 5. Experimental assessment of the subcellular localization of Rv0418, which was selected as positive control protein for
surface/secreted predictions of LipoP 1.0. (A) Immunoblotting assessment of the presence of Rv0418 in TPS: total protein sonicate, W: cell wall,
M: membrane, C: cytosol and F: culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-immune
serum showing no recognition of any mycobacterial protein. Molecular weight marker is shown on the left (P7708S ColorPlus Prestained Protein
Marker, New England Biolabs) and the molecular weight observed for Rv0418 is shown to the right. (B) IEM assessment of the presence of Rv0418 on
the surface of intact M. tuberculosis H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm colloidal
gold particles are indicated by the black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results showed
detection of Rv0418 in TPS and surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g005
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continuously being improved, there are still limitations in their use
[39,40,57].
In conclusion, the accuracy of the subcellular localization
predictions yielded by different computational tools was confirmed
by the experimental evidence gathered in this study showing
experimental confirmation on the secretion of Rv0403c, Rv3630
and Rv1022 for the first time. Moreover, their possible secretory
mechanism is suggested based on the tool that predicted their
secretion (SignalP 3.0, TatP 1.0 and LipoP 1.0, respectively). The
results indicate that secreted/surface proteins can be pre-identified
basedonthoroughdecision-makingprotocolssupportedbystatistical
learning, which would optimize the identification of new drug and
vaccine targets and could be extrapolated to the identification of
other protein sets, either in the same or in other biological agents.
Even though the mycobacterial cell envelope is a complex
structure, it is important to highlight that the Machine Learning
methods followed in this study are a good approximation to the
problem of identifying surface proteins, which compared to other
methodological approaches such as proteomics is a good strategy
for narrowing the search to a given set of proteins before
conducting expensive and time-consuming experimental studies.
Methods
Ethics statement
All rabbits used in this study were taken care according to
procedures established by the Office for Protection from Research
Risks (OPRR, Department of Health and Human Services, USA).
Computational phase: retrieval and analysis of the M.
tuberculosis H37Rv genome
Protein sequences from the M. tuberculosis H37Rv genome were
retrieved from two databases: (1) TubercuList, available at http://
genolist.pasteur.fr/TubercuList/ and (2) Sanger Institute, avail-
able at ftp://ftp.sanger.ac.uk/pub/tb/sequences/TB.pep. Protein
sequences downloaded from these databases were exhaustively
compared in order to obtain depurated protein sets.
Feature-based subcellular localization predictions
(specific approach)
Protein sequences were screened using feature-based tools to
identify signal sequences associated to each of the secretory
pathways (Sec, Tat and lipobox), taking care of selecting the option
Gram-positive bacteria. Prediction of signal sequences for secretion
Figure 6. Experimental assessment of the subcellular localization of the candidate protein Rv1022 predicted as a surface/secreted
by LipoP 1.0. (A) Immunoblotting assessment of the presence of Rv1022 in TPS: total protein sonicate, W: cell wall, M: membrane, C: cytosol and F:
culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-immune serum showing no recognition of
any mycobacterial protein. Molecular weight marker is shown on the left (P7709S ColorPlus Prestained Protein Marker, New England Biolabs) and the
molecular weight observed for Rv1022 is shown to the right. (B) IEM assessment of the presence of Rv1022 on the surface of intact M. tuberculosis
H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm colloidal gold particles are indicated by the
black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results showed detection of Rv1022 in membrane,
culture filtrate and surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g006
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SignalP 3.0 server (http://www.cbs.dtu.dk/services/SignalP/). The
threshold for this feature-based tool was set to a $0.5 score
according to the HMM result. For secretion via the alternative Tat
secretory pathway, we used the TatP 1.0 server (http://www.cbs.
dtu.dk/services/TatP/) to search for Tat motifs between the n and h
regions of the signal peptide sequence, considering a score of $0.5.
Additionally, we used LipoP1.0 (http://www.cbs.dtu.dk/services/
LipoP/) to predict lipoprotein lipobox motifs within the first 70
amino acids of each sequence. Proteins showing the best type II
signalsequence scoreandahighprobabilityofSPaseIIcleavage site
were included in the analysis. SecretomeP 2.0 (http://www.cbs.dtu.
dk/services/SecretomeP/) was used to identify proteins with no
apparent signal sequence that might be secreted via other pathways,
according to a selection threshold of $0.5.
Transmembrane topology in the proteins selected based on the
predictions of the feature-based tools was predicted using
TMHMM 2.0 (http://www.cbs.dtu.dk/services/TMHMM/).
This tool allows identifying the presence, localization and
orientation of transmembrane helices. Taking into account the
number of amino acids expected in a helix (ExpAA), a protein is
likely to cross the membrane or have a signal sequence if this
number is larger than 18; if the helix lies within the first 60
residues (first 60 amino acids), the protein might not have a
transmembrane helix but could instead have a signal sequence.
Phobius (http://phobius.sbc.su.se/) was used in order to
distinguish between a signal sequence (either for secretion via
classical or alternative pathways) and an N-terminal transmem-
brane helix, by identifying possible a-helical conformations in the
h region of the signal sequence that could be mistakenly classified
as a transmembrane region [36].
General subcellular localization predictions (general
approach)
Proteins selected based on the predictions of the feature-based
tools were further analyzed with general subcellular localization
Figure 7. Experimental assessment of the subcellular localization of the candidate protein Rv0835 predicted as a surface/secreted
by LipoP 1.0. (A) Immunoblotting assessment of the presence of Rv0835 in TPS: total protein sonicate, W: cell wall, M: membrane, C: cytosol and F:
culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-immune serum showing no recognition of
any mycobacterial protein. Molecular weight marker is shown on the left (P7708S ColorPlus Prestained Protein Marker, New England Biolabs) and the
molecular weight observed for Rv0835 is shown to the right. (B) IEM assessment of the presence of Rv0835 on the surface of intact M. tuberculosis
H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm colloidal gold particles are indicated by the
black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results showed detection of Rv0835 in TPS, culture
filtrate and surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g007
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(http://www.csbio.sjtu.edu.cn/bioinf/Gpos/), PSORTb v.2.0.4
(http://www.psort.org/psortb/) and PA-SUB v.2.5 (http://pasub.
cs.ualberta.ca:8080/pa/Subcellular). In all cases, predictions were
performed selecting the option Gram-positive bacteria.
Selection of candidate proteins
Proteins predicted to have a signal sequence for secretion via a
specific secretory pathway and the ones identified by SecretomeP
2.0 were compared to the set of 100 membrane proteins reported
by Gu et al. [37] and Sinha et al. [58]. Surface proteins derived
from this comparison and preferably exclusive for each secretory
pathway were selected as positive controls, taking care of selecting
those that had at least one published study confirming their
secretion or surface localization. On the other hand, negative
controls were selected from the list of cytoplasmic proteins
reported in the TBsgc database (http://www.doe-mbi.ucla.edu/
TB/) and were analyzed using the same prediction methodology
applied to candidate proteins and positive controls to confirm the
absence of a signal sequence, localization in a subcellular
compartment different from the surface or extracellular milieu,
and the lack of transmembrane helices.
Likewise, proteins in the M. tuberculosis H37Rv genome
predicted to be secreted preferably via a single pathway were
chosen as candidate proteins in the experimental phase. These
proteins were selected based on a high signal sequence probability
score, as mentioned above. Preferably, only proteins that had no
previous publications were selected.
Furthermore, proteins selected on the basis of the above
mentioned criteria had to be predicted to be located on the cell
surface by any of the general subcellular localization tools,
Figure 8. Experimental assessment of the subcellular localization of Rv0556, which was selected as positive control protein for
surface/secreted predictions of SecretomeP 2.0. (A) Immunoblotting assessment of the presence of Rv0556 in TPS: total protein sonicate, W:
cell wall, M: membrane, C: cytosol and F: culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-
immune serum showing no recognition of any mycobacterial protein. Molecular weight marker is shown on the left (P7709S ColorPlus Prestained
Protein Marker, New England Biolabs) and the molecular weight observed for Rv0556 is shown to the right. (B) IEM assessment of the presence of
Rv0556 on the surface of intact M. tuberculosis H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm
colloidal gold particles are indicated by the black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results
showed detection of Rv0556 in TPS and surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g008
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for prediction in mycobacterial proteins that have high sensitivity
and specificity). Additionally, candidate proteins had to contain at
least one transmembrane helix, except in the case of lipoproteins,
which are anchored to the cell surface via the lipobox motif.
In summary, each secretory pathway included a protein whose
membrane localization had been confirmed by proteomics and
two additional proteins obtained from the prediction analysis
carried out over the entire genome.
Prediction of linear B cell epitopes
Linear B cell epitopes were predicted using AntheProt, which is
available at http://antheprot-pbil.ibcp.fr/ and the BepiPred 1.0
server available at http://www.cbs.dtu.dk/services/BepiPred/.
Linear B cell epitopes predicted by BepiPred were compared to
the values given for each amino acid by AntheProt regarding three
physicochemical profiles: combined antigenicity, hydrophilicity
and solvent accessibility. The values obtained for each profile were
averaged in groups of 20 amino acids. For each protein, regions
having the best averages were considered as good linear B cell
epitopes and their selection involved also their exclusive presence
in M. tuberculosis, as indicated by homology comparison using the
BLASTp tool.
Experimental phase: peptide synthesis
Two 20-amino-acid-long, non-overlapping peptides selected
based on the linear B cell epitope predictions performed for each
protein were chemically synthesized by the multiple solid phase
synthesis methodology [59], using BHA resin (0.7 meq/mg) and t-
boc protected amino acids. Peptides were freeze-dried, purified by
reverse phase high performance liquid chromatography (RP-
HPLC) and characterized by MALDI-TOF mass spectrometry
(Bruker, USA). Cysteine and glycine residues were added at both
ends and oxidization was carried out at pH 7.5 to enable their
polymerization.
Rabbit immunization
Two animals per peptide previously determined to be
nonreactive to M. tuberculosis sonicate were subcutaneously
immunized with each peptide. Each animal received a mixture
Figure 9. Experimental assessment of the subcellular localization of the candidate protein Rv0361 predicted as a surface/secreted
by SecretomeP 2.0. (A) Immunoblotting assessment of the presence of Rv0361 in TPS: total protein sonicate, W: cell wall, M: membrane, C: cytosol
and F: culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-immune serum showing no
recognition of any mycobacterial protein. Molecular weight marker is shown on the left (P7709S ColorPlus Prestained Protein Marker, New England
Biolabs) and the molecular weight observed for Rv0361 is shown to the right. (B) IEM assessment of the presence of Rv0361 on the surface of intact
M. tuberculosis H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm colloidal gold particles are
indicated by the black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results showed detection of Rv0361
in TPS, membrane and surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g009
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Freund’s incomplete adjuvant on days 0, 20 and 40. Sera were
collected before the first immunization (pre-immune sera) and 20
days after the third immunization (immune sera). Proteins for
which sera were already available at the FIDIC’s serum library, as
well as those for which peptides were synthesized for this study, are
shown in Table 3.
M. tuberculosis, M. smegmatis and E. coli cultures and
sonicates
M. tuberculosis H37Rv (ATCC 27294) and Mycobacterium smegmatis
(Paris 4995) were grown in Middlebrook 7H9 Broth with 0.05%
Tween 80 enriched with 10% OADC (Oleic Acid, Albumin,
Dextrose and Catalase) and 0.2% Glycerol for 15 days to mid-log
phase of growth at 37uC and 33uC, respectively [60]. Bacteria
were harvested by centrifugation at 12,500 g for 30 min,
suspended in 16 phosphate buffered saline (PBS) and stored at
220uC. For E. coli TOP10 (Invitrogen, CA, USA), 4 ml of Luria
Bertani (LB) sterile medium were inoculated with the bacteria and
cultured for 16–18 h at 37uC under constant shaking.
Ten grams (wet weight) of mycobacteria and E. coli were
suspended in 20 ml of 16 PBS containing DNase, RNase and
proteinase inhibitor cocktail (1 mM phenylmethylsulfonylfluoride
[PMSF], 1 mM EDTA, 1 mg/ml of leupeptin and 1 mg/ml of
Pepstatin A). Cells were sonicated for 20 min using a Branson 450
Sonifier ultrasonic cell disruptor, setting the amplitude to 4 and the
duty cycle to 90%. The sonicate was centrifuged at 650 g for
20 min, skimmed off and the supernatant was then centrifuged at
36,000 g for 45 min at 4uC. Protein concentration was determined
by the Bicinchoninic Acid (BCA) method [61] using bovine serum
albumin (BSA) as standard. This M. tuberculosis H37Rv total
protein sonicate (TPS) was used in the all immunodetection assays.
E. coli and M. smegmatis sonicates were individually coupled to
CNBr-activated Sepharose 4B (GE Healthcare Life Sciences, NJ,
USA), according to the manufacturer’s recommendations. Rabbit
antisera (pre-immune and immune) were pre-adsorbed on E. coli-
Sepharose and M. smegmatis-Sepharose affinity columns to remove
crossreactive antigens. Briefly, 5 ml of each serum was added to
4 ml of sonicate-Sepharose affinity columns and left in a gentle
rotating/shaking mode for 20 min at room temperature. This
Figure 10. Experimental assessment of the subcellular localization of the candidate protein Rv0178 predicted as a surface/secreted
by SecretomeP 2.0. (A) Immunoblotting assessment of the presence of Rv0178 in TPS: total protein sonicate, W: cell wall, M: membrane, C: cytosol
and F: culture filtrate of M. tuberculosis H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-immune serum showing no
recognition of any mycobacterial protein. Molecular weight marker is shown on the left (P7709S ColorPlus Prestained Protein Marker, New England
Biolabs) and the molecular weight observed for Rv0178 is shown to the right. (B) IEM assessment of the presence of Rv0178 on the surface of intact
M. tuberculosis H37Rv bacilli (magnification: 40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm colloidal gold particles are
indicated by the black arrows. (C) Pre-immune serum showed no recognition of any mycobacterial proteins. The results showed detection of Rv0178
in TPS, membrane and surface of M. tuberculosis H37Rv.
doi:10.1371/journal.pcbi.1000824.g010
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column each time.
Separation of culture filtrate and subcellular fractions
M. tuberculosis H37Rv culture aliquots of 25 ml were centrifuged
at 10,000 g for 20 min at 4uC and the supernatant was filtered
under sterile conditions using a 0.2-mm pore membrane to obtain
the culture filtrate. To obtain the subcellular fractions, the pellet
was washed thrice with 16 PBS, resuspended in proteinase
inhibitor cocktail, sonicated for 15 min on an ice bath (work cycle:
80%, amplitude: 3), let to settle for 15 min at 4uC and again
sonicated same as before. This procedure was carried in two stages
to avoid sample overheating and thus maintain protein integrity.
This sonicate was centrifuged at 3,000 g for 5 min at 4uC, the
pellet (unbroken cells) was discarded and the supernatant was
centrifuged at 27,000 g for 1 h at 4uC. The pellet was resuspended
in lysis buffer containing lysozyme (without DNAse and RNAse)
and centrifuged one more time for 1 h at 4uC and 27,000 g. The
pellet from this centrifugation, which corresponded to the cellular
wall, was resuspended in ammonium bicarbonate, while the
supernatants from the first and second centrifugations were pooled
and centrifuged at 100,000 g for 4 h at 4uC. The supernatant
obtained from this centrifugation was labeled as cytosolic fraction
and centrifuged for 4 h at 100,000 g and 4uC to remove traces of
membrane proteins (pellet). All pellets were pooled and labeled as
membrane fraction.
The cell wall, membrane, cytosolic and culture filtrate were
washed with DNAse-RNAse free lysis buffer, poured into 3500
MWCO dialysis tubing (Spectra/Por, CA, USA) and dialyzed
against 10 mM ammonium bicarbonate for 24 h at 4uC, changing
Figure 11. Experimental assessment of the subcellular localization of the negative control protein Rv0126. (A) Immunoblotting
assessment of the presence of Rv0126 in TPS: total protein sonicate, W: cell wall, M: membrane, C: cytosol and F: culture filtrate of M. tuberculosis
H37Rv, using specific antisera raised in rabbits. PI: assessment of the pre-immune serum showing no recognition of any mycobacterial protein.
Molecular weight marker is shown on the left (P7708S ColorPlus Prestained Protein Marker, New England Biolabs) and the molecular weight observed
for Rv0126 is shown to the right. (B) IEM assessment of the presence of Rv0126 in the cytoplasm of intact M. tuberculosis H37Rv bacilli (magnification:
40,0006). Proteins detected by anti-rabbit antibody conjugated to 10-nm colloidal gold particles are indicated by the black arrows. (C) Pre-immune
serum showed no recognition of any mycobacterial proteins. The results showed detection of Rv0126 in TPS and the cytoplasm of M. tuberculosis
H37Rv.
doi:10.1371/journal.pcbi.1000824.g011
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polyethylenglycol, quantified by BCA [62,63] and stored at 270uC.
Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblotting
Proteins from the M. tuberculosis TPS and subcellular fractions
were separated in a discontinuous SDS-PAGE system using a 10–
20% (w/v) acrylamide gradient and commercial molecular mass
markers (New England Biolabs Inc. MA, USA and BIO-RAD,
CA, USA) to estimate protein molecular weights. One milligram of
each sample was loaded per gel and transferred to nitrocellulose
membrane (Hybond 203c, Pharmacia). Membranes were blocked
with 5% skimmed milk diluted in TBS–T (0.02 M Tris–HCl at
pH 7.5, 0.05 M NaCl and 1% Tween 20), cut into strips and
incubated with pre-adsorbed rabbit sera diluted 1:100 in blocking
solution. Strips were then incubated for 1 h with 1:4,500 alkaline-
phosphatase-conjugated anti-rabbit IgG antibody (Vector Labo-
ratories, Inc. CA, USA), followed by five washes with TBS–T. The
reaction was developed with NBT/BCIP kit (Promega, WI, USA),
according to the manufacturer’s recommendations.
Each membrane strip was incubated for 1 h at room
temperature with a 1:100 dilution of pre-immune or immune
sera diluted in blocking solution. Anti-rabbit IgG antibody coupled
to alkaline phosphatase (Vector Laboratories, Inc.) diluted 1:5,000
in blocking solution was used as secondary antibody. Immunore-
activity was developed by a colorimetric enzymatic reaction
(NBT/BCIP). Hyperimmune anti-M. tuberculosis TPS serum was
used as positive control. Additionally, an SDS-gel containing
culture filtrate proteins and all subcellular fractions was stained
with Colloidal Coomassie Blue.
Immunoelectron microscopy (IEM)
An inoculum of M. tuberculosis H37Rv was resuspended and
fixed for 2 h using 4% paraformaldehyde/0.5% glutaraldehyde in
16 PBS and then dehydrated through 15 min immersions in a
series of graded ethanol (50%, 70%, 90%, and 100% twice),
centrifuging samples for 15 min at 2,500 g between immersions.
Bacilli were gradually embedded and polymerized in LR-White
resin (SPI supplies, PA, USA), using accelerator for cold
polymerization as specified by the manufacturer (1ml accelera-
tor/500 ml resin). Ultrathin sections (400 nm thick) were mounted
on 300-mesh nickel grids coated with collodion support. For
immunolabeling, grids were blocked with 5% BSA–0.1% Tween
20 for 30 min and subsequently washed carefully drop by drop
with 0.5% BSA–0.1% Tween 20 in 16PBS.
Grids were incubated overnight at 4uC with a 1:20 dilution of
primary antibody (either pre-immune or immune sera), washed
thrice as before and immersed in a 1:50 dilution of anti-rabbit
antibody coupled to 10-nm colloidal gold particles for 1 h at room
temperature [64]. For each protein, rabbits’ pre-immune sera were
used as negative control and sera raised against M. tuberculosis TPS
were used as positive control, respectively. Finally, grids were
stained with 6% uranyl acetate to enhance image contrast, then
washed with distilled water and dried before being examined in a
Morgani 268 digital transmission electron microscopy.
Figure 13 summarizes all steps followed in the computational
phase as well as in the experimental phase.
Supporting Information
Table S1 Proteins predicted by SignalP 3.0. This file contains
the predictions yielded by SignalP 3.0 for the complete genome of
M. tuberculosis H37Rv with their corresponding transmembrane
topology and general localization predictions. In the last table
column entitled ‘‘shared’’, proteins that were also positively
predicted by any of the other feature-based tools are labeled with
an ‘‘x’’ (File format: .xls).
Found at: doi:10.1371/journal.pcbi.1000824.s001 (0.33 MB XLS)
Figure 12. Positive control of immunoblotting assays. (A) Colloidal Coomassie Blue Staining of SDS-gel containing W: cell wall, M: membrane,
C: cytosol fractions and F: culture filtrate of M. tuberculosis H37Rv. (B) Recognition of several protein bands of strong intensity by sera raised against a
crude protein sonicate of M. tuberculosis H37Rv (TPS) and in all subcellular fractions and the culture filtrate. (C) Positive control of IEM studies: Serum
raised against crude sonicate of M. tuberculosis H37Rv (TPS) recognized proteins in all subcellular compartments (magnification: 40,0006).
doi:10.1371/journal.pcbi.1000824.g012
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predictions yielded by TatP 1.0 on the complete genome of M.
tuberculosis H37Rv with their corresponding transmembrane
topology and general localization predictions. In the last table
column entitled ‘‘shared’’, proteins that were also positively
predicted by any of the other feature-based tools are labeled with
an ‘‘x’’ (File format: .xls).
Found at: doi:10.1371/journal.pcbi.1000824.s002 (0.12 MB XLS)
Table S3 Proteins predicted by LipoP 1.0. This file contains the
predictions yielded by LipoP 1.0 on the complete genome of M.
tuberculosis H37Rv with their corresponding transmembrane
topology and general localization predictions. In the last table
column entitled ‘‘shared’’, proteins that were also positively
predicted by any of the other feature-based tools are labeled with
an ‘‘x’’ (File format: .xls).
Found at: doi:10.1371/journal.pcbi.1000824.s003 (0.05 MB XLS)
Table S4 Proteins predicted by SecretomeP 2.0. This file
contains the predictions yielded by SecretomeP 2.0 on the
complete genome of M. tuberculosis H37Rv with their correspond-
ing transmembrane topology and general localization predictions.
In the last table column entitled ‘‘shared’’, proteins that were also
positively predicted by any of the other feature-based tools are
labeled with an ‘‘x’’ (File format: .xls).
Found at: doi:10.1371/journal.pcbi.1000824.s004 (0.45 MB XLS)
Table S5 Computational prediction on the proteins identified
experimentally by Gu et al. and Sinha et al. This file contains the
predictions yielded by the feature-based tools for 100 proteins
identified experimentally in the proteomics studies carried out by
Gu et al. and Sinha et al. with their corresponding transmembrane
topology and general localization predictions. In the last table
column entitled ‘‘shared’’, proteins that were also positively
predicted by any of the other feature-based tools are labeled with
the number ‘‘1’’ (File format: .xls).
Found at: doi:10.1371/journal.pcbi.1000824.s005 (0.08 MB XLS)
Table S6 Negative controls. This file contains the predictions
yielded by the machine-learning tools for the 9 cytoplasmic
proteins reported in TBsgc (File format: .xls).
Found at: doi:10.1371/journal.pcbi.1000824.s006 (0.03 MB XLS)
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